Less than a year since the pandemic began, two potential vaccine candidates are on the horizon. Even as the COVID-19 pandemic continues its deadly march, one thing is clear: Scientific understanding of the new coronavirus and advances in fighting it have progressed with stunning speed. Here are five key things we’ve learned about COVID-19 since it began to spread in the U.S.
Contact: Leigh Hopper, lhopper@usc.edu or (310) 308-0405
“Back in March people were calling me to ask me how long they needed to soak the can of beans in bleach before they could bring it into the house. Everybody was sort of hyper vigilant and hyper-paranoid.
“We’ve since learned that airborne virus in poorly ventilated indoor spaces — emitted by maskless people as they speak or sing or simply breathe — is the likely cause of most transmissions and the reason why indoor bars and restaurants are so risky.”
“We don’t like the new message because it means you’ve got to carry on limiting your social interaction, not seeing family and friends. But we’ve got to get through these next two to three months of winter. This is crunch time.”
Paula Cannon is a Distinguished Professor of Molecular Microbiology & Immunology at the Keck School of Medicine of USC.
Contact: pcannon@usc.edu
“When community spread of COVID-19 first began emerging in the United States, a primary concern — and rightly so — was spread among nursing homes. We observed the heavy impact of COVID-19 illness and death among the elderly. As the pandemic progressed, additional inequities surfaced. Data indicated historically marginalized groups were being disproportionately affected by the virus.
“These disparities in COVID-19 morbidity and mortality were reported nationwide. In New York City—an early epicenter of COVID-19 in the U.S.—Hispanic and Black people comprised 34% and 28% of deaths but only 29% and 22% of the population, respectively, according to data from the New York State Department of Health. Data from a healthcare system in California showed non-Hispanic Black patients had 2.7 times the odds of hospitalization compared with non-Hispanic white patients, after adjusting for age, sex, comorbidities, and income. In recent months, we have seen increasing incidence and mortality among younger adults here in California, particular among Hispanic and Black people.
“Researchers at USC and elsewhere are working to elucidate how various factors (including, clinical, behavioral, community, and public health measures) contribute to COVID-19 mortality disparities so that possible interventions can be developed to decrease the disproportionate burden of the pandemic on vulnerable populations.”
Erika Garcia is an assistant professor of preventive medicine at the Keck School of Medicine of USC.
Contact: garc991@usc.edu
“When we run chest CT scans or X-rays on patients with COVID-19, we typically see scattered patchy areas of inflammation in the lungs, which we call atypical pneumonia. These patients usually suffer from a cough, difficulty breathing or chest pain, fatigue and fever.
“What we have found very surprising is that some patients with COVID-19 have no such symptoms. Instead, they present with abdominal pain, or even other symptoms, such as a stroke or an eye inflammation. Yet when we image their lungs, we find COVID-19. On the flip side, much less frequently, patients come in with a cough and fever, and chest imaging reveals that the lungs are clear or have minimal signs of inflammation.
“This may have to do with the fact that COVID-19 affects almost every organ in the body, not just the lungs as was originally thought when the pandemic first began.”
Ali Gholamrezanezhad is an assistant professor of clinical radiology at the Keck School of Medicine of USC.
Contact: gholamre@usc.edu
“What we’ve learned since COVID began is that death is not the only outcome to fear. Millions of people of all ages may face lifelong, and potentially life-shortening health impacts. The emphasis on fatalities and hospitalizations misses this.
“New research is showing that some people are unable to return to normal activities after COVID. These ‘long-haulers’ have shortness of breath, extreme fatigue, a racing heartbeat. They have lung scarring or ongoing neurological issues. You don’t want to get this.
“There are significant gaps in our conduct of research that would help us understand the full impact of this better. We currently have limited insights into long-term effects, as only a limited number of studies are being pursued to establish that. It is a catch-22 situation where the healthcare system can only start responding to this challenge after the healthcare system (jointly with research) has conducted the systematic research to understand the scale of the challenge.”
Peter Kuhn is the Dean’s Professor of Biological Sciences at the USC Dornsife College of Letters, Arts and Sciences.
Contact: pkuhn@usc.edu
“We started the epidemic with scarce testing that took too long. Now, access to rapid testing is more widely available.
“However, there’s a dangerous narrative out there in which people assume that getting a negative test result means it’s safe to go home for Thanksgiving. All that tells you is you don’t have detectable virus right now.
“You may be early in the course of infection and thus undetectable. Testing negative doesn’t get you out of having to take other precautions like wearing a mask or avoiding indoor gatherings with people outside your household.”
Susan Butler-Wu is an associate professor of clinical pathology at the Keck School of Medicine of USC.
Contact: butlerwu@usc.edu
“The public health messaging on masks was initially unclear and has been muddled by political arguments. However, we as learned more about this novel disease, it quickly became clear: Masks are an important part of keeping infections low and allowing businesses to remain open.
“A vaccine appears to be on the horizon and people may think masks are soon to be a thing of the past — but that’s not the case. Even once a vaccine becomes available, it is going to take a long time to distribute doses and vaccinate millions of people. Thankfully, pharmacists will play a key role in helping public health, hospitals, and clinics quickly accomplish this task. (California Gov. Gavin Newsom signed a bill that will allow pharmacists to administer the vaccine.) Until then, masks will continue to be an important part of the strategy for preventing infections.”
Richard Dang is an assistant professor of clinical pharmacy at the USC School of Pharmacy. He is president-elect of the California Pharmacists Association and chair of its COVID-19 Task Force.
Contact: rdang@usc.edu
